Stock Comparison

AXSM vs VRTX

Axsome Therapeutics Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

AXSM

Axsome Therapeutics Inc

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$12.44B

$124.70B

P/E (TTM)

—

29.2

Forward P/E

333.3

25.8

Price/Sales

17.6

10.2

Price/Book

227.8

6.4

EV/EBITDA

-14.8

24.0

Dividend Yield

—

Profitability

Net Margin

-26.60%

35.50%

Operating Margin

-32.80%

38.10%

Return on Equity

-349.40%

24.20%

Return on Assets

-16.80%

12.10%

Growth (YoY)

Revenue Growth

57.40%

7.80%

Earnings Growth

0.00%

61.40%

Price & Risk

Beta

0.6

0.3

52-Week High

$260.19

$507.92

52-Week Low

$96.09

$362.50

Analyst Target

$276.47

$548.69

Compare AXSM and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.